Matches in SemOpenAlex for { <https://semopenalex.org/work/W4361946108> ?p ?o ?g. }
Showing items 1 to 74 of
74
with 100 items per page.
- W4361946108 abstract "<div>Abstract<p><b>Purpose:</b> Ovarian carcinoma no longer responsive to surgery and chemotherapy remains an incurable disease. Alternative therapeutic options remain desperately needed.</p><p><b>Patients and Methods:</b> We describe a heavily pretreated patient with ovarian cancer with recurrent disease experiencing a remarkable clinical response to treatment with the anti-PD1 immune checkpoint inhibitor pembrolizumab. The clinical, pathological, and genomic characteristics of this exceptional ovarian cancer responder were carefully investigated using immunohistochemistry (IHC), quantitative multiplex fluorescence methods (i.e., automated quantitative analysis, AQUA) and whole-exome sequencing (WES) techniques.</p><p><b>Results:</b> The patient harbored a recurrent/metastatic radiation and chemotherapy-resistant high-grade ovarian carcinoma with clear cell features. While progressing on any standard treatment modality, she demonstrated a remarkable complete response to the anti-PD1 immune checkpoint inhibitor pembrolizumab. WES results were notable for the presence a relative low number of mutations (tumor mutation load/Mb = 4.31, total mutations = 164) and a peculiar structural variant disrupting the 3′ region of the <i>PD-L1</i> gene causing aberrant PD-L1 surface expression as confirmed by IHC and AQUA technology. Heavy infiltration of the PD-L1–mutated and PD-L1–overexpressing tumor with T-cell lymphocytes (i.e., CD4<sup>+</sup>/CD8<sup>+</sup> TIL), CD68<sup>+</sup> macrophages, and CD20<sup>+</sup> B cells was detected in the surgical specimen strongly suggesting immune evasion as a key mechanism of tumor growth and survival. Patient's complete clinical responses remain unchanged at the time of the writing of this report with no significant side effects reported to date.</p><p><b>Conclusions:</b> Anti-PD1 inhibitors may represent a novel treatment option for recurrent/metastatic human tumors refractory to salvage treatment harboring <i>PD-L1</i> gene structural variations causing aberrant PD-L1 expression. <i>Clin Cancer Res; 24(14); 3282–91. ©2018 AACR</i>.</p><p><i>See related commentary by Lheureux, p. 3233</i></p></div>" @default.
- W4361946108 created "2023-04-05" @default.
- W4361946108 creator A5005582681 @default.
- W4361946108 creator A5010339370 @default.
- W4361946108 creator A5021257078 @default.
- W4361946108 creator A5026827320 @default.
- W4361946108 creator A5027326018 @default.
- W4361946108 creator A5029434966 @default.
- W4361946108 creator A5046857977 @default.
- W4361946108 creator A5061703014 @default.
- W4361946108 creator A5062006821 @default.
- W4361946108 creator A5065267721 @default.
- W4361946108 creator A5084497328 @default.
- W4361946108 date "2023-03-31" @default.
- W4361946108 modified "2023-10-16" @default.
- W4361946108 title "Data from Exceptional Response to Pembrolizumab in a Metastatic, Chemotherapy/Radiation-Resistant Ovarian Cancer Patient Harboring a PD-L1-Genetic Rearrangement" @default.
- W4361946108 doi "https://doi.org/10.1158/1078-0432.c.6525833" @default.
- W4361946108 hasPublicationYear "2023" @default.
- W4361946108 type Work @default.
- W4361946108 citedByCount "0" @default.
- W4361946108 crossrefType "posted-content" @default.
- W4361946108 hasAuthorship W4361946108A5005582681 @default.
- W4361946108 hasAuthorship W4361946108A5010339370 @default.
- W4361946108 hasAuthorship W4361946108A5021257078 @default.
- W4361946108 hasAuthorship W4361946108A5026827320 @default.
- W4361946108 hasAuthorship W4361946108A5027326018 @default.
- W4361946108 hasAuthorship W4361946108A5029434966 @default.
- W4361946108 hasAuthorship W4361946108A5046857977 @default.
- W4361946108 hasAuthorship W4361946108A5061703014 @default.
- W4361946108 hasAuthorship W4361946108A5062006821 @default.
- W4361946108 hasAuthorship W4361946108A5065267721 @default.
- W4361946108 hasAuthorship W4361946108A5084497328 @default.
- W4361946108 hasBestOaLocation W43619461082 @default.
- W4361946108 hasConcept C121608353 @default.
- W4361946108 hasConcept C126322002 @default.
- W4361946108 hasConcept C143998085 @default.
- W4361946108 hasConcept C204232928 @default.
- W4361946108 hasConcept C2776694085 @default.
- W4361946108 hasConcept C2777701055 @default.
- W4361946108 hasConcept C2778326572 @default.
- W4361946108 hasConcept C2780057760 @default.
- W4361946108 hasConcept C2780427987 @default.
- W4361946108 hasConcept C2780851360 @default.
- W4361946108 hasConcept C502942594 @default.
- W4361946108 hasConcept C71924100 @default.
- W4361946108 hasConceptScore W4361946108C121608353 @default.
- W4361946108 hasConceptScore W4361946108C126322002 @default.
- W4361946108 hasConceptScore W4361946108C143998085 @default.
- W4361946108 hasConceptScore W4361946108C204232928 @default.
- W4361946108 hasConceptScore W4361946108C2776694085 @default.
- W4361946108 hasConceptScore W4361946108C2777701055 @default.
- W4361946108 hasConceptScore W4361946108C2778326572 @default.
- W4361946108 hasConceptScore W4361946108C2780057760 @default.
- W4361946108 hasConceptScore W4361946108C2780427987 @default.
- W4361946108 hasConceptScore W4361946108C2780851360 @default.
- W4361946108 hasConceptScore W4361946108C502942594 @default.
- W4361946108 hasConceptScore W4361946108C71924100 @default.
- W4361946108 hasLocation W43619461081 @default.
- W4361946108 hasLocation W43619461082 @default.
- W4361946108 hasOpenAccess W4361946108 @default.
- W4361946108 hasPrimaryLocation W43619461081 @default.
- W4361946108 hasRelatedWork W2740354603 @default.
- W4361946108 hasRelatedWork W2777867648 @default.
- W4361946108 hasRelatedWork W2970048128 @default.
- W4361946108 hasRelatedWork W3215402659 @default.
- W4361946108 hasRelatedWork W4206362823 @default.
- W4361946108 hasRelatedWork W4225127290 @default.
- W4361946108 hasRelatedWork W4290958849 @default.
- W4361946108 hasRelatedWork W4310834173 @default.
- W4361946108 hasRelatedWork W4313355991 @default.
- W4361946108 hasRelatedWork W4362706485 @default.
- W4361946108 isParatext "false" @default.
- W4361946108 isRetracted "false" @default.
- W4361946108 workType "article" @default.